Life

‘Breaking Bread’ Showcases the A-Sham Food Festival in Israel

Phone of the future – The Sun

    Roche: FDA Approves Vabysmo To Treat Two Vision-threatening Retinal Conditions

    Roche (RHHBY) said FDA has approved Vabysmo (faricimab-svoa) for the treatment of neovascular or “wet” age-related macular degeneration and diabetic macular edema. Neovascular AMD and DME are two leading causes of vision loss worldwide. The company noted that Vabysmo is the first and only FDA-approved injectable eye medicine for nAMD and DME that improves and maintains vision with treatments from one to four months apart in the first year following four initial monthly doses.

    “Vabysmo provides a new approach to treating vision-threatening retinal conditions through a mechanism of action that targets two pathways simultaneously,” said Levi Garraway, Roche’s Chief Medical Officer and Head of Global Product Development.

    Vabysmo will be available in the United States in the coming weeks, Roche said.

    H&M Group Q4 Net Income Increases – Quick Facts

    H & M Hennes & Mauritz AB (HNNMY.PK,HMRZF.PK,HEN.L) reported that its fourth quarter net income increased to 4.62 billion Swedish kronor from 2.48 billion Swedish kronor, prior year. Earnings per share was 2.79 kronor compared to 1.50 kronor, prior year. Net sales increased by 8 percent to 56.81 billion kronor from 52.55 billion kronor. Net sales in local currencies increased by 11 percent, for the quarter.

    Full year profit after tax increased to 11.01 billion Swedish kronor from 1.24 billion kronor, corresponding to earnings of 6.65 kronor per share compared to 0.75 kronor per share, last year. Net sales increased by 6 percent to 198.97 billion kronor. Net sales in local currencies increased by 12 percent, for the full year.

    For the period 1 December 2021 to 31 January 2022, the company estimates sales in local currencies to increase by 20 percent from last year.

    The board is proposing to the annual general meeting that a dividend of 6.50 kronor per share is paid. The first payment of 3.25 kronor will be made in May and the second payment of 3.25 kronor will be made in November.

    The board will also propose to the annual general meeting 2022 that the board is authorised to pass resolutions on the buyback of shares for a total amount of 3 billion Swedish kronor in the period up to and including the 2023 annual general meeting.

    Helmerich & Payne Inc. Q1 Loss Narrows

    Helmerich & Payne Inc. (HP) released Loss for first quarter that decreased from last year

    The company’s bottom line came in at -$51.36 million, or -$0.48 per share. This compares with -$70.43 million, or -$0.66 per share, in last year’s first quarter.

    Excluding items, Helmerich & Payne Inc. reported adjusted earnings of -$47.28 million or -$0.45 per share for the period.

    The company’s revenue for the quarter rose 66.3% to $409.78 million from $246.38 million last year.

    Helmerich & Payne Inc. earnings at a glance (GAAP) :

    -Earnings (Q1): -$51.36 Mln. vs. -$70.43 Mln. last year.
    -EPS (Q1): -$0.48 vs. -$0.66 last year.
    -Revenue (Q1): $409.78 Mln vs. $246.38 Mln last year.

    For This Menu, Start With Dessert

    A tangerine flan, prepared in advance, ends this midwinter menu of brightly dressed chicories and rich pork chops from David Tanis.

    By David Tanis

    Artists and the Food That Inspires Them

    ‘The Ucross Cookbook’ provides recipes and testimonials from an artist residency program founded in 1981.


    By Florence Fabricant

    Fine Tinned Seafood From the Cervo’s and Hart’s Team

    Canned cod livers, sardines and sockeye salmon are available from the new offshoot, Minnow.


    By Florence Fabricant

    Govt. does switch operation of ₹1,19,701 crore

    The government has been undertaking conversion or switch operations with the objective of smoothening the liability profile as well as for market development.

    The Government of India to smoothen its liability profile has done a conversion transaction with the Reserve Bank of India (RBI) on January 28, 2022 for an amount of ₹1,19,701 crore (face value).

    “The transaction involved buying back securities maturing in FY 2022-23, FY 2023-24 and FY 2024-25 from the Reserve Bank and issuing fresh securities for equivalent market value, to make the transaction cash neutral,” the RBI said in a statement.

    The transactions were carried out using Financial Benchmarks India Pvt. Ltd. (FBIL) prices as on January 28, 2022, it added.

    The Government of India has been undertaking conversion or switch operations with market participants as well as with the RBI with the objective of smoothening the liability profile as well as for market development. This is part of these operations.

    ‘Breaking Bread’ Showcases the A-Sham Food Festival in Israel

    The festival was created by Dr. Nof Atamna Ismaeel, in an effort to create bridges between communities.


    By Florence Fabricant